Medications

Imbruvica approved for mantle cell lymphoma

(HealthDay)—Imbruvica (ibrutinib) has been approved by the U.S. Food and Drug Administration to treat mantle cell lymphoma (MCL), a rare but aggressive form of blood cancer.

Diseases, Conditions, Syndromes

TB infection rates set to 'turn clock back to 1930s'

During the 1930s, dedicated sanitaria and invasive surgery were commonly prescribed for those with the infection - usually caused by Mycobacterium tuberculosis, which the editors describe as "the most successful human pathogen ...

Diseases, Conditions, Syndromes

Scientists gain new understanding of latent tuberculosis

Scientists at the Forsyth have gained new insight on how Tuberculosis (TB) remains a global epidemic. Although drugs have been available to fight TB for 50 years, the disease still infects nearly 2.2 billion people worldwide ...

Medical research

New implant replaces impaired middle ear

(Medical Xpress)—Functionally deaf patients can gain normal hearing with a new implant that replaces the middle ear. The unique invention from the Chalmers University of Technology has been approved for a clinical study. ...

Diseases, Conditions, Syndromes

Combating MRSA: Researchers study community-associated strain

The Caenorhabditis elegans, a small worm called a nematode, scurrying across a Petri dish has helped lead to discoveries about community-associated MRSA (methicillin-resistant Staphylococcus aureus).

page 10 from 13